Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial.

Dimitrios Alexopoulos, Gerasimos Dimitropoulos, Periklis Davlouros, Ioanna Xanthopoulou, George Kassimis, Eleana F Stavrou, George Hahalis, Aglaia Athanassiadou, None, Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping. Jacc-cardiovascular Interventions. ,vol. 4, pp. 403- 410 ,(2011) , 10.1016/J.JCIN.2010.12.011

Jean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, Ana Pena, Anne Bellemain-Appaix, Olivier Barthélémy, Guillaume Cayla, Farzin Beygui, Gilles Montalescot, Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis Journal of the American College of Cardiology. ,vol. 56, pp. 134- 143 ,(2010) , 10.1016/J.JACC.2009.12.071

Dirk Sibbing, Siegmund Braun, Tanja Morath, Julinda Mehilli, Wolfgang Vogt, Albert Schömig, Adnan Kastrati, Nicolas von Beckerath, Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. Journal of the American College of Cardiology. ,vol. 53, pp. 849- 856 ,(2009) , 10.1016/J.JACC.2008.11.030

Gennaro Sardella, Simone Calcagno, Massimo Mancone, Raffaele Palmirotta, Luigi Lucisano, Emanuele Canali, Rocco Edoardo Stio, Mauro Pennacchi, Angelo Di Roma, Giulia Benedetti, Fiorella Guadagni, Giuseppe Biondi-Zoccai, Francesco Fedele, Pharmacodynamic Effect of Switching Therapy in Patients With High On-Treatment Platelet Reactivity and Genotype Variation With High Clopidogrel Dose Versus Prasugrel Circulation: Cardiovascular Interventions. ,vol. 5, pp. 698- 704 ,(2012) , 10.1161/CIRCINTERVENTIONS.112.972463

Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt, C. Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, Stephen D. Wiviott, Venu Menon, Eugenia Nikolsky, Victor Serebruany, Marco Valgimigli, Pascal Vranckx, David Taggart, Joseph F. Sabik, Donald E. Cutlip, Mitchell W. Krucoff, E. Magnus Ohman, Philippe Gabriel Steg, Harvey White, Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium Circulation. ,vol. 123, pp. 2736- 2747 ,(2011) , 10.1161/CIRCULATIONAHA.110.009449

Harrington RA Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Thorsén M. PLATO Investigators, Freij A, None, Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes The New England Journal of Medicine. ,vol. 361, pp. 1045- 1057 ,(2009) , 10.1056/NEJMOA0904327

Jean-Philippe Collet, Thomas Cuisset, Grégoire Rangé, Guillaume Cayla, Simon Elhadad, Christophe Pouillot, Patrick Henry, Pascal Motreff, Didier Carrié, Ziad Boueri, Loic Belle, Eric Van Belle, Hélène Rousseau, Pierre Aubry, Jacques Monségu, Pierre Sabouret, Stephen A. O'Connor, Jérémie Abtan, Mathieu Kerneis, Christophe Saint-Etienne, Olivier Barthélémy, Farzin Beygui, Johanne Silvain, Eric Vicaut, Gilles Montalescot, Bedside monitoring to adjust antiplatelet therapy for coronary stenting. The New England Journal of Medicine. ,vol. 367, pp. 2100- 2109 ,(2012) , 10.1056/NEJMOA1209979

Matthew J Price, Peter B Berger, Paul S Teirstein, Jean-François Tanguay, Dominick J Angiolillo, Douglas Spriggs, Sanjeev Puri, Mark Robbins, Kirk N Garratt, Olivier F Bertrand, Michael E Stillabower, Joseph R Aragon, David E Kandzari, Curtiss T Stinis, Michael S Lee, Steven V Manoukian, Christopher P Cannon, Nicholas J Schork, Eric J Topol, Gravitas Investigators, None, Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA. ,vol. 305, pp. 1097- 1105 ,(2011) , 10.1001/JAMA.2011.290

Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Joseph R Walker, Tabassome Simon, Elliott M Antman, Eugene Braunwald, Marc S Sabatine, Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis The Lancet. ,vol. 376, pp. 1312- 1319 ,(2010) , 10.1016/S0140-6736(10)61273-1

Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe, Gilles Montalescot, Witold Ruzyllo, Shmuel Gottlieb, Franz-Joseph Neumann, Diego Ardissino, Stefano De Servi, Sabina A. Murphy, Jeffrey Riesmeyer, Govinda Weerakkody, C. Michael Gibson, Elliott M. Antman, Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes The New England Journal of Medicine. ,vol. 357, pp. 2001- 2015 ,(2007) , 10.1056/NEJMOA0706482